Endoscopic treatment of Zenker’s diverticulum: comparable treatment outcomes in treatment-naïve and pretreated patients by Manzeneder, Johannes et al.
Research Article
Endoscopic Treatment of Zenker’s Diverticulum: Comparable
Treatment Outcomes in Treatment-Naïve and Pretreated Patients
Johannes Manzeneder , Christoph Römmele, Carolin Manzeneder, Alanna Ebigbo,
Helmut Messmann, and Stefan Karl Goelder
Department of Internal Medicine III at the University Hospital Augsburg, Germany
Correspondence should be addressed to Johannes Manzeneder; sjmanze@gmail.com
Received 28 June 2020; Revised 14 February 2021; Accepted 22 February 2021; Published 16 March 2021
Academic Editor: Agata Mulak
Copyright © 2021 Johannes Manzeneder et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
Background and Aims. Flexible endoscopic treatment plays an important role in the treatment of Zenker’s diverticulum (ZD). This
study analyzes long-term symptom control and the rate of adverse events in treatment-naïve patients and patients with recurrence,
using the stag beetle knife junior (sb knife jr). Methods. From August 2013 to May 2019, 100 patients with symptomatic ZD were
treated with flexible endoscopy using the sb knife jr. Before treatment, as well as 1 and 6 months afterwards, symptoms were
obtained by a nine-point questionnaire, with symptoms weighted from 0 to 4. Results. Overall, 126 interventions were
performed. The median follow-up period was 41 months (range 7-74). For the three most frequent symptoms, regurgitation,
dysphagia, and dry cough, a significant reduction of the mean score could be achieved, from 2.85/3.45/2.85 before the initial
treatment to 0.56/1.09/0.98 6 months later. 17 patients were retreated because of recurrence. Out of these, 12 patients underwent
a 2nd, 4 patients a 3rd, and 1 patient a 4th session, respectively. The mean dysphagia score for successfully treated patients could
be reduced from initially 2.34 to 0.49/0.33/0.67 after the 1st/2nd/3rd session, the frequency of dysphagia from 3.45 to
0.92/1.00/1.33, and the score for regurgitations from 2.85 to 0.35/1.00/0.67. In first-line treatment, as well as in retreatment, no
severe adverse event occurred. Conclusion. Patients with ZD can be treated safely and effectively with the sb knife jr.
Retreatment leads to equal symptom relief as compared to a successful first-line treatment and is not associated with a higher
rate of adverse events.
1. Introduction
Zenker’s diverticulum (ZD) is a rare disease of the laryngo-
pharynx that appears mainly in elderly people. It emerges
in a weak part of the inferior pharyngeal constrictor muscle
called the triangle of Killian which is located superior to the
upper esophageal sphincter [1, 2]. Patients with ZD primarily
suffer from dysphagia and regurgitations. But there are a
number of other symptoms such as halitosis, aspiration, dry
cough, and vomiting in varying frequency and intensity asso-
ciated with ZD [1, 3].
For a long time, the treatment had been either surgical or
peroral with a rigid endoscope mostly done by Ear-Nose-
Throat (ENT) physicians. In the midnineties, an approach
with flexible endoscopy was presented for the first time [4,
5]. Since then, a huge variety of techniques and devices have
been introduced [6]. Currently, flexible endoscopy plays an
important role in the treatment of ZD. Basically, endoscopic
approaches have in common the incision of the diverticular
bridge with varying success and recurrence rates. However,
the recurrence rate remains an issue of controversy, especially
when comparing endoscopic and surgical techniques [1, 6, 7].
The aim of this study is to investigate symptom control
and the rate of adverse events in flexible endoscopic treat-
ment of ZD with the stag beetle knife junior (sb knife jr) in
first-line therapy as well as in the therapy of symptomatic
recurrence.
2. Methods
2.1. Patients. Data from patients with symptomatic ZD who
were treated at the Department of Internal Medicine III at
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the University Hospital Augsburg, Germany, from August
2013 to May 2019 were evaluated. All patients were treated
with flexible endoscopy and the sb knife jr as the cutting
device. Patients who had had a previous treatment, either
surgical or endoscopic, were excluded.
2.2. Endoscopic Procedure and Devices. All interventions were
done by two experienced endoscopists (H.M., S.K.G.). A sin-
gle treatment protocol was implemented.
On the day prior to the intervention, a gastroscopy was
performed to clean the diverticulum of food remnants, to
measure the size, and to inspect the diverticulum in order
to exclude patients with a candida infection. Diverticulotomy
was performed in deep sedation with midazolam, pethidine,
and propofol. First, a soft diverticuloscope (ZD overtube,
ZDO-22/33 Cook Medical, Limerick, Ireland) was placed to
stretch the diverticular bridge between the esophagus and
the diverticular lumen. The endoscope (GIF-HQ190, Olym-
pus Europa, Hamburg, Germany) was inserted, and the
mucomyotomy was done with the sb knife jr (Sumitomo
Bakelite, Tokyo, Japan). This is a scissors-shaped device with
an opening width of 3.5mm that can be rotated by 360
degrees. Additional to electrical cutting, the device is able to
simultaneously compress the tissue. Due to the mechanical
effect, the directly adjacent tissue is more strongly bonded
together (Figure 1). The electrosurgical current was gener-
ated by the VIO 300 unit (Endocut Q Effect 1, soft coagula-
tion 40W, Erbe, Tübingen, Germany).
The technique was modified in the course of the study;
initially, only one incision was done in the middle of the
diverticular bridge. Later, two incisions were made and the
part in-between was resected with a snare (double incision
and snare resection (DISR)) in order to get a broader incision
of the diverticular bridge. The incision was then continued in
the middle to the base of the diverticulum [8]. Regardless of
the technique used, the aim was to completely cut the fibers
of the upper esophageal sphincter. Also, the treatment of
recurrences was done using these described techniques.
Each patient received a single dose of antibiotics (2 g ceftri-
axone) during the intervention. Clipping of the bottom of the
incision line was not done routinely. Prophylactic clipping to
prevent delayed bleeding or perforation was performed in
some cases, based on the judgment of the endoscopist.
Recurrence was defined as a relapse of symptoms with
substantial limitations in a patient’s quality of life. Adverse
events were classified according to the American Society for
Gastrointestinal Endoscopy (ASGE) [9].
2.3. Postprocedural Management and Follow-Up. On the day
after the intervention, a contrast swallow was performed. If
there was no evidence of perforation, the transition to a soft
diet for five days was commenced.
The symptoms of the patients were recorded before treat-
ment as well as one and six months after the intervention by a
questionnaire developed in our clinic [3, 10]. The question-
naire contains nine points: Dakkak and Bennett’s dysphagia
score [11]; the frequency of dysphagia, odynophagia, regurgi-
tation, vomiting, dry cough, halitosis, and nocturnal awaken-
ing due to Zenker-related symptoms; and the general
condition of the patient including body weight, duration of
symptoms, and weight loss. The symptoms were registered
on an ordinal scale with values from zero to four (Table 1).
All patients were informed about the possibility of readmis-
sion in case of recurring symptoms. Additionally, patients
who stated a high point value (>12) in the questionnaire six
months after the initial intervention were called to evaluate
whether further treatment was necessary.
2.4. Statistics. The evaluation was performed using Microsoft
Excel. Data were stated as mean, median, and standard devi-
ation. For statistical analysis, different t-tests and chi-squared
tests were used. Statistical significance was assumed at a p
value of <0.05.
2.5. Ethical Considerations. All patients gave written consent
to the intervention. The study was conducted in accordance
with the Declaration of Helsinki. The study protocol was
(a) (b) (c) (d) (e)
(f) (g) (h) (i) (j)
Figure 1: (a) Symptomatic ZD of a 73-year-old male patient. (b) Fixation of the diverticulum with an overtube. (c) Incision of the mucosa and
the upper muscular fibers of the diverticular bridge. (d) Cutting down the diverticular bridge with the sb knife jr. (e) Final result after the first
session. (f–j) Second session because of recurrence 16 months later.
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approved by the institutional review board (Reference num-
ber: BKF 2018-19).
3. Results
3.1. Patients and Symptoms.Overall, 100 patients with symp-
tomatic ZD were treated. 36 (36%) of them were female, and
the median age was 71 years (range 42-92 years). All divertic-
ula were stadium III or IV according to the radiological clas-
sification of Brombart [12]. The median size was 20mm
(range 10-45mm). The median body mass index (BMI) was
26.1 kg/m2 (range 17.3-38.0 kg/m2), and the mean weight loss
before treatment was 2.3 kg (range 0-20 kg).
In total, 126 interventions were performed (1.26 session-
s/patient). Of these, 60 (47.6%) were done in the modified
DISR technique.
In three cases, cutting off the diverticular bridge was not
completed in the first session and a second intervention
had to be planned. The reason for this was a cyst in the diver-
ticular bridge, a large asymmetric diverticulum, and, in the
third case, suspicion of a small perforation, which was not
confirmed afterwards.
Clips were used in 21 interventions (range 1-5). In most
cases, the clipping was done only for prophylactic reasons
(n = 14, 66.7%). Clips were applied four times (19.0%) for
bleeding control and in three cases (14.3%) because of sus-
pected perforation.
The rate of return of the questionnaire was 91% after one
month and 90% after six months. The median follow-up was
41 months (range 7-74) (Table 2).
The patients showed a wide variety of symptoms
(Table 3). The most frequent symptoms were regurgitation,
dysphagia, and dry cough (mean score before intervention
2.85/3.45/2.85). Permanent dysphagia occurred in 62% of
patients and in 27% more than once a week. After treatment,
there was a significant reduction of symptoms. One month
after the intervention, the mean score for regurgitations was
0.30 (p < 0:001, compared to the value prior to the treat-
ment), for dysphagia 0.62 (p < 0:001), and for dry cough
0.78 (p < 0:001). After one month, the majority of patients
(64%) had no dysphagia. Also, six months after the interven-
tion, a significant reduction of symptoms could be reported
Table 1: Content of the questionnaire.
0 1 2 3 4
Recorded symptoms
Frequency of dysphagia Never <1/mth <1/wk >1/wk Permanent
Dysphagia score No dysph. Solid food Soft food Fluids Aphagia∗
Odynophagia Never <1/mth <1/wk >1/wk Permanent
Regurgitation Never <1/mth <1/wk >1/wk Permanent
Halitosis Never <1/mth <1/wk >1/wk Permanent
Vomiting Never <1/mth <1/wk >1/wk Permanent
Nocturnal awakening Never <1/mth <1/wk >1/wk Permanent
Chronic cough Never <1/mth <1/wk >1/wk Permanent
Additional information
General condition Very good Good Satisfactory Bad Very bad
Duration of symptoms Open answer
Most compromising sympt. Open answer
Weight loss Open answer
∗Aphagia means the inability to swallow saliva. dysph.: dysphagia; sympt.: symptoms; wk: week; mth: month.
Table 2: Demographic and clinical characteristics.
Total number of patients 100
Median age 71 (42-92)
Sex (female/male) 36/64
Median diverticular size (mm) 20 (10-45)
Total number of interventions 126
Number of the modified DISR technique 60 (47.6%)
Median follow-up (months) 41 (7-74)
Median body mass index (kg/m2) 26.1 (17.3-38.0)
Mean weight loss (kg) 2.3 (0-20)
Values express absolute numbers with (range).
Table 3: Frequency of symptoms of all patients before, one month,
and six months after the initial treatment (mean value).
Before 1 month 6 months
n = 100 n = 91 n = 90
Dysphagia 3.45 0.62∗∗∗ 1.09∗∗∗
Odynophagia 1.45 0.22∗∗∗ 0.36∗∗∗
Regurgitation 2.85 0.30∗∗∗ 0.56∗∗∗
Halitosis 1.15 0.25∗∗∗ 0.27∗∗∗
Vomiting 0.79 0.13∗∗∗ 0.09∗∗∗
Nocturnal awakening 1.97 0.05∗∗∗ 0.23∗∗∗
Dry cough 2.85 0.78∗∗∗ 0.98∗∗∗
Values express the following frequency scores: 0: never, 1: <1x/month, 2:
>1x/month, 3: >1x/week, and 4: permanent. n = number of evaluated
questionnaires. ∗∗∗t-test significance p < 0:001 compared to the value prior
to the first treatment.
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(median score for regurgitations 0.56, p < 0:001; for dyspha-
gia 1.09, p < 0:001; and for dry cough 0.98, p < 0:001).
3.2. Adverse Events. Intraprocedural bleeding occurred in 16
interventions (12.7%). Most cases (15) were stopped by coag-
ulation with the sb knife jr or by a hemostatic grasper (Coa-
grasper Hemostatic Forceps FD-411 QR, Olympus Europa,
Hamburg, Germany). In four cases, clips (range 1-2, Olym-
pus Medical Systems Corp., Tokyo, Japan) were used. In
three cases, a combination of a hemostatic grasper and
hemoclips was applied. Termination of the procedure due
to intraprocedural bleeding was not necessary since all bleed-
ing cases could be treated successfully. There was no case of
delayed bleeding. Procedures performed using the DISR
technique showed a slightly lower bleeding rate, but this
was not significant (DISR 12.2%, single incision 18.6%, and
p = 0:39).
In four cases, a perforation was suspected during the
intervention. Of these, one intervention had to be stopped
prematurely. In five other cases, contrast swallow after the
treatment showed a small perforation. In case a perforation
was suspected, nil diet and clinical observation were extended
and antibiotics were given for several days. But in all these
cases, the further clinical course was uneventful. Emphysema
was not observed in any of the patients.
Three patients suffered severe or prolonged postproce-
dural pain. One patient was monitored overnight in the inten-
sive care unit to rule out serious adverse events as a reason for
his pain. All these patients were managed conservatively.
Another patient developed a hemodynamically relevant
tachycardia (focal atrial tachycardia) after the intervention,
most probably because she had not taken her antiarrhythmic
medication prior to the intervention. She spent one night in
the intensive care unit and was treated with amiodarone.
In all 126 interventions, no severe adverse event was
observed. There was no case of mediastinitis or abscess.
3.3. Recurrence. After initial treatment, 17 patients (17%)
developed a recurrence (Figure 2). Nine (9%) recurrences
occurred within the first six months after treatment, and
eight (8%) later than six months. Five patients needed a third
session and one a fourth.
The demographic and clinical characteristics of patients
who developed a recurrence did not differ from patients
without recurrence (Table 4). Furthermore, the size of the
diverticulum did not correlate with the risk of recurrence
(p = 0:26). The median diverticular size in patients with
recurrence was 15mm (range 5-35mm). Considering the
recurrence rate, there was no significant difference between
DISR and single incision technique (DISR 17.1%, single inci-
sion 16.9%, and p = 0:99). Also, the use of clips during the
first intervention had no influence on the recurrence rate
(clips used 10.5%, no clips 18.5%, and p = 0:40).
After retreatment, symptom scores of patients with
recurrence could be reduced to a level comparable to patients
who were recurrence-free after one intervention. Dakkak and
Bennett’s dysphagia score was reduced from 2.34 to 0.49
(p < 0:001) in patients without recurrence. Those patients
who developed a recurrence after the initial treatment had
an average score of 1.31 six months after the first interven-
tion. Six months after the second treatment, the score was
0.33 (p = 0:01) for patients with no further recurrence and
1.50 for patients with a second recurrence. Besides one
patient, all remaining patients could be treated successfully
in the third session. Their dysphagia score was 0.67 six
months after the third intervention which is comparable to
the values of those patients who did not develop a further
recurrence after the first or second treatment. Due to the
small number of patients in this group (available data from
three out of four patients), a reasonable statistical calculation
is not possible in that case (Figure 3).
The same effect was seen for the frequency of dysphagia
and regurgitation. Regarding the frequency of dysphagia,
the value declined from 3.45 to 0.92 (p < 0:001)/1.00 (p =
0:02)/1.33 in successfully treated patients (six months after
the 1st/2nd/3rd session) and for regurgitation from 2.85 to
0.35 (p < 0:001)/1.00 (p < 0:01)/0.67. Patients with recur-
rence needed in total a mean of 2.35 sessions (range 2-4) to
achieve symptom control.
No bleeding occurred in the treatment of recurrences
which means that the rate of bleeding was significantly lower
in the retreatment group compared to the initial intervention
group (p = 0:04). Also, there was no other severe adverse
event in the treatment of recurrences.
4. Discussion
The strength of this study is the large cohort of patients and
the follow-up over a median of 41 months (range 7-74).
Besides the study of Huberty et al. [13], this is one of the larg-
est prospectively documented cohort of patients with symp-
tomatic ZD treated by a flexible endoscopic approach. Due
to the long-term follow-up period, late recurrences were also
included. Of course, there might be patients that are lost to
follow-up so that recurrences are not detected. But this prob-
lem is similar to other interventional studies concerning ZD.
The recurrence rate of 17% is comparable to the results of


















Figure 2: Flow chart of patients with recurrence. Recurrence:
recurring symptoms after a temporary improvement. ∗103
sessions in 100 patients due to three two-stage treatments.
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In surgical transcervical series, the reported recurrence
rate varies widely, depending on the surgical technique, from
1.9% for open suspension [14] to 21% for invagination of the
diverticulum [1].
In our study, patients who developed recurrence could
be divided into two major groups. In group one (9%), after
an initial distinct improvement of symptoms, recurrence
occurred early within a few months after treatment. In
the second group (8%), the patients were already in remis-
sion before they developed recurrent symptoms (median 16
months, range 8-26). A reason for the early recurrences
might be an incomplete initial dissection of the cricophar-
yngeal muscle in the first session. Probably, the myotomy
for those patients was not wide or long enough. An incom-
plete myotomy of the upper esophageal sphincter has
already been discussed in the literature as a possible cause
of recurrence [7, 15]. Why other patients, after an initially
successful treatment with good symptom control, suffer a
recurrence after a longer period of time cannot be conclu-
sively explained at present.
There were no severe adverse events. In contrast, surgical
approaches have a low but relevant number of severe adverse
events such as mediastinitis or permanent palsy of the re-
current laryngeal nerve. Moreover, surgical meta-analysis
shows a small number of therapy-related deaths [1, 14].
Also, in approaches with rigid endoscopes, some major
adverse events, such as abscesses requiring external drain-
age, occurred [16].
Although the rate of recurrence in our cohort is slightly
higher, this study has shown that treatment can be easily
repeated with a high success rate. Repetition of a surgical
treatment might be more difficult and challenging due to
scarring tissue. In our cohort, retreatment was technically
feasible, and in one patient, retreatment was performed four
times. Retreatment of those patients was not associated with
a higher rate of adverse events, and the rate of bleeding was
even significantly lower. Dissection of the scar and remaining
muscle tissue with flexible endoscopy is technically not more
challenging than the initial treatment. Patients with recur-
rence could achieve the same control of their symptoms as
patients without recurrence. Eventually, even patients who
needed several sessions (mean 2.35 sessions) could be treated
successfully.
Tunneling myotomy has been reported recently; how-
ever, further studies are needed to clarify its long-term effec-
tiveness [17, 18]. It is also unclear if a tunneled myotomy
could be repeated in case of recurrence.
A limitation of this study is that there is no direct com-
parison to other therapeutic methods, especially a transcervi-
cal surgical approach. A randomized study with different
treatment paths would be able to compare the rate of recur-
rence and adverse events.
5. Conclusion
Symptomatic ZD can be controlled with endoscopic treat-
ment using the sb knife jr in a safe and effective way. Patients
with recurrence can be retreated without an increased risk of
adverse events and with a high success rate. Patients with
recurrence can ultimately achieve the same long-term symp-
tom control as treatment-naïve patients.
Data Availability
The data on which this study is based have been deposited in
the study secretariat of the Department of Internal Medicine
III at the University Hospital Augsburg.
Table 4: Descriptive characteristics before treatment stratified by no recurrence/recurrence.
Nonrecurrence Recurrence p value
Total number of patients 83 17
Median follow-up (months) 44 (7-74) 39 (7-69)
Median age 71 (42-92) 73 (49-85) 0.90
Sex (female/male) 32/51 4/13 0.24
Median diverticular size (mm) 20 (10-45) 27.5 (20-40) 0.26
Median body mass index (kg/m2) 25.8 (17.3-38.0) 27.1 (17.5-34.5) 0.70
Mean weight loss (kg) 2.1 (0-20) 2.3 (0-20) 0.83















































Figure 3: Dysphagia score of patients with and without recurrence
after each session. Mean dysphagia score prior to initial treatment
and six months after each session. Dysphagia score: 0: no
dysphagia, 1: solid food, 2: soft food, 3: fluids, and 4: aphagia. ∗∗∗t
-test significance p < 0:001, ∗t-test significance p < 0:05.
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